Sandbox: Reddy: Difference between revisions
No edit summary |
|||
| Line 8: | Line 8: | ||
==[[Roseola historical perspective|Historical Perspective]]== | ==[[Roseola historical perspective|Historical Perspective]]== | ||
The Roseola virus was was first isolated in 1986 from patients who had been diagnosed with HIV AIDS or a lymphoproliferative disorder by stimulating their interleukin 2 peripheral blood mononuclear cells (PBMCs)<ref name="pmid2876520">{{cite journal| author=Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M et al.| title=Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. | journal=Science | year= 1986 | volume= 234 | issue= 4776 | pages= 596-601 | pmid=2876520 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2876520 }} </ref> | |||
==[[Roseola classification|Classification]]== | ==[[Roseola classification|Classification]]== | ||
Revision as of 18:54, 22 May 2017
|
Roseola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sandbox: Reddy On the Web |
|
American Roentgen Ray Society Images of Sandbox: Reddy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]:Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
Historical Perspective
The Roseola virus was was first isolated in 1986 from patients who had been diagnosed with HIV AIDS or a lymphoproliferative disorder by stimulating their interleukin 2 peripheral blood mononuclear cells (PBMCs)[1]
Classification
Pathophysiology
Causes
Differentiating Any Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
- ↑ Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M; et al. (1986). "Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders". Science. 234 (4776): 596–601. PMID 2876520.